BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24332797)

  • 1. Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients.
    Asanghanwa M; Gorus FK; Weets I; der Auwera BV; Aminkeng F; Mbunwe E; Goubert P; Verhaeghen K; Sobngwi E; Wenzlau JM; Hutton JC; Pipeleers DG; Keymeulen B; Mbanya JC; van Schravendijk C
    Diabetes Res Clin Pract; 2014 Jan; 103(1):97-105. PubMed ID: 24332797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
    Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
    Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
    Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
    Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.
    Vermeulen I; Weets I; Asanghanwa M; Ruige J; Van Gaal L; Mathieu C; Keymeulen B; Lampasona V; Wenzlau JM; Hutton JC; Pipeleers DG; Gorus FK;
    Diabetes Care; 2011 Aug; 34(8):1760-5. PubMed ID: 21715527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
    Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
    Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different interaction of onset age and duration of type 1 diabetes on the dynamics of autoantibodies to insulinoma-associated antigen-2 and zinc transporter 8.
    Kawasaki E; Oikawa Y; Okada A; Kanatsuna N; Kawamura T; Kikuchi T; Terasaki J; Miura J; Itoh Y; Hanafusa T
    J Diabetes Investig; 2021 Apr; 12(4):510-515. PubMed ID: 32696593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.
    Achenbach P; Hummel M; Thümer L; Boerschmann H; Höfelmann D; Ziegler AG
    Diabetologia; 2013 Jul; 56(7):1615-22. PubMed ID: 23539116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma-associated antigen-2 autoantibodies in the identification and characterization of Japanese type 1 diabetes.
    Kawasaki E; Oikawa Y; Okada A; Kanatsuna N; Kawamura T; Kikuchi T; Terasaki J; Miura J; Ito Y; Hanafusa T
    J Diabetes Investig; 2020 Sep; 11(5):1181-1187. PubMed ID: 32175683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DPD epitope-specific glutamic acid decarboxylase (GAD)65 autoantibodies in children with Type 1 diabetes.
    Bansal N; Hampe CS; Rodriguez L; O'Brian Smith E; Kushner J; Balasubramanyam A; Redondo MJ
    Diabet Med; 2017 May; 34(5):641-646. PubMed ID: 26802570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?
    Lounici Boudiaf A; Bouziane D; Smara M; Meddour Y; Haffaf EM; Oudjit B; Chaib Mamouzi S; Aouichat Bouguerra S
    Curr Res Transl Med; 2018 Mar; 66(1):1-7. PubMed ID: 29487039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and
    Gorus FK; Balti EV; Messaaoui A; Demeester S; Van Dalem A; Costa O; Dorchy H; Mathieu C; Van Gaal L; Keymeulen B; Pipeleers DG; Weets I;
    Diabetes Care; 2017 Aug; 40(8):1065-1072. PubMed ID: 28701370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.
    Gorus FK; Goubert P; Semakula C; Vandewalle CL; De Schepper J; Scheen A; Christie MR; Pipeleers DG
    Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of ZnT8 antibody in relation to phenotype and SLC30A8 polymorphism in adult autoimmune diabetes: results from the HUNT study, Norway.
    Sørgjerd EP; Skorpen F; Kvaløy K; Midthjell K; Grill V
    Autoimmunity; 2013 Feb; 46(1):74-9. PubMed ID: 23061550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5.
    Xiang Y; Huang G; Shan Z; Pan L; Luo S; Yang L; Shi L; Li Q; Leslie RD; Zhou Z
    Acta Diabetol; 2015 Dec; 52(6):1121-7. PubMed ID: 26239144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An important minority of prediabetic first-degree relatives of type 1 diabetic patients derives from seroconversion to persistent autoantibody positivity after 10 years of age.
    Vermeulen I; Weets I; Costa O; Asanghanwa M; Verhaeghen K; Decochez K; Ruige J; Casteels K; Wenzlau J; Hutton JC; Pipeleers DG; Gorus FK;
    Diabetologia; 2012 Feb; 55(2):413-20. PubMed ID: 22095238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
    Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Zinc Transporter 8 Autoantibodies Following Type 1 Diabetes Onset: The Type 1 Diabetes Genetics Consortium Autoantibody Workshop.
    Wenzlau JM; Frisch LM; Hutton JC; Fain PR; Davidson HW
    Diabetes Care; 2015 Oct; 38 Suppl 2(Suppl 2):S14-20. PubMed ID: 26405067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ-specific autoantibodies in Chinese patients newly diagnosed with type 1 diabetes mellitus.
    Pan S; Wu T; Shi X; Xie Z; Huang G; Zhou Z
    Endocr J; 2020 Jul; 67(7):793-802. PubMed ID: 32295990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose tolerance and beta-cell function in islet autoantibody-positive children recruited to a secondary prevention study.
    Andersson C; Carlsson A; Cilio C; Cedervall E; Ivarsson SA; Jonsdottir B; Jönsson B; Larsson K; Neiderud J; Lernmark A; Elding Larsson H;
    Pediatr Diabetes; 2013 Aug; 14(5):341-9. PubMed ID: 23469940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.
    Brorsson C; Vaziri-Sani F; Bergholdt R; Eising S; Nilsson A; Svensson J; Lernmark Å; Pociot F;
    Autoimmunity; 2011 Mar; 44(2):107-14. PubMed ID: 20836749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.